Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

Kirchhof Paulus; Haeusler Karl Georg; Blank Benjamin; De Bono Joseph; Callans David; Elvan Arif; Fetsch Thomas; Van Gelder Isabelle C.; Gentlesk Philip; Grimaldi Massimo; Hansen Jim; Hindricks Gerhard; Al-Khalidi Hussein R.; Massaro Tyler; Mont Lluis; Nielsen Jens Cosedis; Noelker Georg; Piccini Jonathan P.; De Potter Tom; Scherr Daniel; Schotten Ulrich; Themistoclakis Sakis; Todd Derick; Vijgen Johan; Di Biase Luigi

首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

【24h】

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

机译：患者患者中风患者进行心室颤动烧蚀的患者

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims It is recommended to perform atrial fibrillation ablation with continuous anticoagulation. Continuous apixaban has not been tested.

机译：目的建议使用连续抗凝进行心房颤动消融。连续的Apixaban尚未测试。

著录项

来源
《European Heart Journal: The Journal of the European Society of Cardiology》 |2018年第32期|共14页
作者
Kirchhof Paulus; Haeusler Karl Georg; Blank Benjamin; De Bono Joseph; Callans David; Elvan Arif; Fetsch Thomas; Van Gelder Isabelle C.; Gentlesk Philip; Grimaldi Massimo; Hansen Jim; Hindricks Gerhard; Al-Khalidi Hussein R.; Massaro Tyler; Mont Lluis; Nielsen Jens Cosedis; Noelker Georg; Piccini Jonathan P.; De Potter Tom; Scherr Daniel; Schotten Ulrich; Themistoclakis Sakis; Todd Derick; Vijgen Johan; Di Biase Luigi;
展开▼
作者单位

Univ Birmingham Inst Cardiovasc Sci IBR 136 Wolfson Dr Birmingham B15 2TT W Midlands England;

Atrial Fibrillat NETwork Assoc AFNET Munster Germany;

Atrial Fibrillat NETwork Assoc AFNET Munster Germany;

Univ Birmingham Inst Cardiovasc Sci IBR 136 Wolfson Dr Birmingham B15 2TT W Midlands England;

Hosp Univ Penn 3400 Spruce St Philadelphia PA 19104 USA;

Isala Heart Ctr Zwolle Zwolle Netherlands;

Clin Res Inst Munich Germany;

Univ Groningen Univ Med Ctr Groningen Groningen Netherlands;

Sentara Cardiovasc Res Inst Norfolk VA USA;

Osped Gen Reg R Miulli Acquaviva Delle Fonti Italy;

Gentofte Univ Hosp Hellerup Denmark;

Leipzig Heart Ctr Abt Rhythmol Leipzig Germany;

Duke Univ Sch Med Dept Biostat &

Bioinformat Durham NC 27706 USA;

DCRI Durham NC USA;

Univ Barcelona Hosp Clin Barcelona Barcelona Spain;

Aarhus Univ Hosp Dept Cardiol Aarhus Denmark;

Ruhr Univ Bochum Herz &

Diabeteszentrum NRW Bad Oeynhausen Germany;

DCRI Durham NC USA;

OLV Aalst Cardiovasc Ctr Aalst Belgium;

Med Univ Graz Dept Cardiol Graz Austria;

Atrial Fibrillat NETwork Assoc AFNET Munster Germany;

Osped Angelo Venice Italy;

Liverpool Heart &

Chest Hosp Liverpool Merseyside England;

Jessa Ziekenhuis Campus Virga Jesse Hasselt Belgium;

Montefiore Hosp Albert Einstein Coll Med New York NY USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Atrial fibrillation; Ablation; Anticoagulation; Bleeding; Stroke; Brain MRI;

机译：心房颤动;消融;抗凝;出血;中风;脑MRI;

相似文献

外文文献
中文文献
专利

1. Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation [J] . Kirchhof Paulus, Haeusler Karl Georg, Blank Benjamin, European Heart Journal: The Journal of the European Society of Cardiology . 2018,第32期

机译：患者患者中风患者进行心室颤动烧蚀的患者
2. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [J] . Basil S. Lewis, Bernard J. Gersh, Cetin Erol, Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease . 2015,第4期

机译：房颤患者的血压控制和中风或全身性栓塞的风险：阿哌沙班减少房颤的卒中和其他血栓栓塞事件的结果（ARISTOTLE）
3. Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation [J] . Ukaigwe Anene, Shrestha Pragya, Karmacharya Paras, Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing . 2017,第2期

机译：与维生素K拮抗剂相比，疟原虫和不间断的脂蛋白治疗的疗效和安全性的荟萃分析与心房颤动的导管消融的患者相比
4. Analysis of multiscale entropy characteristics of heart rate variability in patients with permanent atrial fibrillation for predicting ischemic stroke risk [C] . Ryo Matsuoka, Kohzoh Yoshino, Eiichi Watanabe, IEEE International Conference on Bioinformatics and Biomedicine . 2018

机译：永久性心房纤颤患者心率变异性的多尺度熵特征分析以预测缺血性中风风险
5. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
6. Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation [O] . Paulus Kirchhof, Karl Georg Haeusler, Benjamin Blank, -1

机译：阿哌沙班用于有中风风险的房颤消融患者
7. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation : Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial [O] . Rao, Meena P, Halvorsen, Sigrun, Wojdyla, Daniel, 2015

机译：心房颤动患者的血压控制和中风或全身性栓塞的风险：阿哌沙班减少房颤的中风和其他血栓栓塞事件的结果（ARISTOTLE）

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

摘要

著录项

相似文献

相关主题

期刊订阅